Kelly-Croswell Lisa 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Jul 19, 2022
Insider Transaction Report
Form 4
Kelly-Croswell Lisa
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-07-18+30,000→ 30,000 totalExercise: $8.13Exp: 2032-07-17→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments over 36 months measured from July 18, 2022 subject to Reporting Person's continuous service status as of each such date.